By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Intarcia Therapeutics, Inc. 

155 Seaport Boulevard
11th Floor
Boston  Massachusetts  02210  U.S.A.
Phone: 617-936-2500 Fax: n/a


Key Statistics

Ownership: Private

Web Site: Intarcia


Drug Discovery

Company News
Intarcia Announces Presentations At American Diabetes Association Of Two Successful FREEDOM Phase 3 Trials For ITCA 650 -- A GLP-1 RA For Type 2 Diabetes 6/8/2015 10:06:37 AM
Intarcia 's Kurt Graves Named An EY Entrepreneur Of The Year 2015 6/8/2015 7:22:25 AM
Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions Of The American Diabetes Association In Boston 6/3/2015 11:15:10 AM
Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 6/2/2015 1:58:07 PM
Intarcia Names Emad Rizk, MD, To Board Of Directors 5/19/2015 11:01:12 AM
Intarcia Named To "CNBC Disruptor 50" List: One Of Only Two Biopharma Companies Named 5/18/2015 10:53:00 AM
Intarcia Appoints James P. Brady Vice President, Human Resources 5/4/2015 9:24:42 AM
Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead Itca 650 Launch In U.S. 5/4/2015 9:23:50 AM
Boston Startup Intarcia Nabs $225 Million in New Financing, Looks to Double Employment 4/28/2015 5:58:29 AM
Intarcia Therapeutics, Inc. And Numab AG Sign Multi-Asset Collaboration To Develop Once-Yearly Therapies In Diabetes, Obesity, and Autoimmune Indications 3/20/2015 6:42:57 AM